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Background: evaluate the effectiveness of TachoSil® sponge on distal pancreatectomy remnant stump in reducing the rate and severity of post-operative pancreatic fistula (POPF)
Methods:
All consecutive patients requiring distal pancreatectomy were randomized in 45 centers. Principal endpoint: onset of "clinically relevant" POPF. Univariate and multivariate analyses searched for predictive factors. 
Results

Of 270 patients randomized in 45 centers (134 with
TachoSil®
Introduction
While distal pancreatic resections are performed less frequently than other pancreatectomies (1), the rate of post-operative pancreatic fistula (POPF) is high, ranging from 5% (2) to 64% (3-5), according to the definition used (4).
Several procedures have been proposed to reduce the rate and/or severity of POPF after distal pancreatectomy (3): decreasing digestive tract secretions (6), main duct ligation (7), various techniques of division and/or stump closure (1, 5, (8) (9) (10) , different types and durations of abdominal drainage (11, 12) , and stump reinforcement with omentum, absorbable or non-absorbable mesh or biological glue (8, (13) (14) (15) (16) (17) (18) . While some reinforcement materials have a mechanical action, reducing the traction on the sutured edges, others act by enhanced healing (14) . TachoSil®, a sponge composed of horse collagen, impregnated with human thrombin and fibrinogen, stabilized by albumin, combines enhanced healing while exercising a hemostatic role (19) and has been used to improve hemostasis and bilistasis on the surface of the divided liver (18).
Several uncontrolled studies seem to indicate that absorbable mesh reinforcement could reduce the POPF rate after distal pancreatectomy (13, 14) . One randomized study has shown that Seamguard ® or Peristrips Dry ® reinforcement of stapled stump closure was effective in decreasing the fistula rate (17). However,
to date, only one controlled trial has studied the role of TachoSil® for stump closure in distal pancreatectomy (19), concluding that TachoSil® did not reduce the overall POPF rate.
The goal of the present study was to report the results of a French multicenter randomized controlled study evaluating the role of the TachoSil® sponge in reducing the rate and the severity of pancreatic POPF after distal pancreatectomy, separating clinically silent from clinically relevant POPF.
Methods
Patients
Patients requiring complete removal of the distal pancreas for benign or malignant tumors of the pancreatic body or tail were eligible for this randomized controlled trial. Inclusion criteria required: life expectancy of at least six months, written informed consent before randomization, no history of allergy to human thrombin and fibrinogen or collagen, no preoperative signs of chronic pancreatitis, and absence of indications for simple enucleation or intra-abdominal anastomosis, including pancreatoenterostomy (to eliminate fistula related to the breakdown of these anastomoses (19)). Patients were randomized to receive the sponge, or not, only after the distal pancreas had been removed, the stump was closed and the surgeon was sure that the TachoSil® sponge could be applied under satisfactory conditions.
Intervention
Surgery could be performed either via laparotomy or laparoscopy, with or without splenectomy, and in case of splenic preservation, with ligature (but preserving the short gastric vessels, as described by Warshaw (20)) or not of the splenic vessels. The pancreatic stump had to be closed, either manually or stapled, as per surgeon's choice. Selective main pancreatic duct closure (suture) was not mandatory but was recommended whenever feasible. The TachoSil® sponge was placed on the stump without sutures, overlapping the closure line by at least 2.5 cm and held there for at least 3 minutes to ensure that it stuck to the stump. Additional techniques such as abdominal drainage, omentoplasty and/or application of biological glue were left to the appreciation of the surgeon.
Definition of post-operative pancreatic fistula (POPF)
POPF was defined according to the International Study Group on Pancreatic Fistula (ISGPF) (21) as any measurable amount of drainage fluid, with amylase concentration greater than 3 times the upper limit of normal in the serum on or after post-operative day 3, irrespective of its color or aspect, exteriorized through a drain or retrieved during reoperation or via percutaneous (sonography or CT-guided) aspiration.
Definition of severity
This study was double blinded: neither the patients nor the independent committee whose role was to evaluate the severity of M A N U S C R I P T
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6 POPF were aware of the allocations. Patients were categorized into two groups of POPF (17, 21, 22) : one without any clinical signs suggestive of any postoperative complication including patients without any signs of POPF and patients with grade A severity (with no clinical impact (mainly no prolonged hospital stay)), categorized as being "clinically silent", the other "clinically relevant" (with impact on the patient's hospital course), including Grades B and C severity.
Judgment criteria
The primary endpoint was the onset of "clinically relevant" POPF.
The secondary endpoints were: a) the overall POPF rate (ISGPF Grades A+B+C), b) interval between operation and the onset of POPF, c) median duration of post-operative stay in intensive care and/or resuscitative care units and overall hospital stay, d) number of post-operative complication(s) (other than POPF), e) adverse event(s) i.e. any potentially harmful manifestation related or not to the product under investigation, and f) mortality.
Follow-up
All patients underwent routine physical examination: daily during hospitalization and at three months (± 15 days) after operation, date at which the diagnosis of POPF and mortality were definitively determined.
Adverse events related to TachoSil®
All adverse events were reported immediately, examined and categorized by an independent data safety monitoring board (DSMB): the causality (not related, possibly related or probably related) was evaluated (23).
Statistical methods
Randomization was centralized by a vocal server and stratified according to the approach (laparotomy or laparoscopy). The and risks were fixed at 0.05 and 0.10, respectively, providing 90% power (one-sided test). Based on an expected decrease in the POPF rate from 30% to 15%, the number of patients necessary to satisfy these hypotheses was 262 patients (131 in each group). No intermediary analysis was planned. The predictive factors for the onset of "clinically relevant" POPF were analyzed by univariate and multivariate (step-wise regression) analyses. The log rank test was used to compare variables related to durations. No statistically significant differences were found in patient demographics (gender, age or body mass index) (table 1).
Results
Two
The final pathology reports of the resected specimen showed that 128/270 patients (47.4 %) had benign disease while 142 (52.6 %) had malignant disease (p=0.223). Most cancers were pancreatic adenocarcinoma (26.7% of the whole population) (table 2).
No statistically significant differences were noted between the two groups as concerns the duration of operation, the number of patients admitted to and duration of patient stay in intensive care and/or resuscitation units or overall duration of hospital stay (Table   3) (Table 4) .
POPF
Of the 270 patients, 150 (55.6%) sustained a POPF (ISGPF Grades A, B and C) of which 74 (49.3%) were clinically relevant while 76 (50.7%) were clinically silent (27.4% and 28.1%, respectively, of the total number of patients) (table 5).
Comparison of patients with or without TachoSil®
Clinically relevant POPF Forty-one patients (30.6%) had a clinically relevant POPF in the TachoSil® group vs. 33 (24.3%) in the control group (p=0.276) ( Table 5 ). The odds ratio (OR) was 1.376 with a 95% confidence interval (95%CI) equal to [0.877-2.160]). The hypothesis that clinically relevant POPF occurred less often when TachoSil® was used, cannot be retained.
POPF (ISGPF Grades A, B and C)
No statistically significant difference was noted between patients with overall POPF in either group: 73 (54.5%) in the TachoSil® group vs. 77 (56.6%) in controls (p=0.807) ( Table 5) 
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There was no statistically significant difference found between the two groups as concerns the interval between operation and the onset of clinical POPF (logrank test: p=0.957) or in the 10 patients undergoing surgical operation or drainage of an intra-abdominal collection after hospitalization: 7 vs. 3, respectively (p=0.217).
Prognostic factors of POPF
In univariate analysis, no statistically significant difference was 
Safety
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According to the DSMB, 756 adverse events were considered to be "not related", while 85 were considered as "possibly related" to the use of TachoSil ®. However, none of these adverse events were reported to be related to the onset of any post-operative complication.
Morbidity
Overall, there were 45 post-operative complications (table 7) .
Nevertheless, there was no statistically significant difference found between patients with or without TachoSil® or in patients sustaining POPF or not.
Mortality
One death occurred in the group randomized to TachoSil®, due to acute respiratory distress, while two deaths occurred in the group without TachoSil®, one related to shock associated with peritonitis and the other due to respiratory failure secondary to pulmonary embolism in a patient with infection and unexpected rapidly generalized cancer.
Discussion
Our results showed that the application of TachoSil® sponge on the proximal remnant after distal pancreatectomy reduced neither the rate nor the severity of POPF. This is the second negative study on the use of TachoSil® in this indication (19). As highlighted recently (25, 26) , it is timely and highly relevant to publish well-conducted negative studies in order M A N U S C R I P T
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13 to avoid publication and reporting bias, more and more prevalent today, and a real threat to the validity of decision-making for the care of our patients.
While the primary endpoint and the results were close to those in the only previous randomized study on the same topic with the same product (19), our study differed in that: a) we showed that TachoSil® was ineffective for exclusively clinically relevant POPF as well as for all grades of POPF, b) the evaluation of patient outcome for both the diagnosis of POPF and the causality of adverse events was double blinded, c) the power of making a false negative conclusion was twice as strong (our beta error (10%) was half that of the Italian study (20%)). Of note, as others (17, 22), our trial clearly distinguishes itself from the Italian study (19) in that we separated the clinically relevant from the clinically silent grade A POPF. Otherwise, the overall POPF (including Grade A+B+C) would have been 55.6%, still slightly less than the 65% reported in the Italian study (19) .
In multivariable analysis, we found that hand-sewn closure of the pancreatic stump and ligation of the splenic vessels in case of splenic preservation were statistically significantly associated with an increased risk for clinically relevant POPF. This is of interest in the modern era where more and more distal pancreatectomies are being performed laparoscopically (5, 17): stapled stump closure and splenic vessel preservation are the preferred methods in laparoscopic distal pancreatectomy.
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At least 18 observational (9), two randomized controlled trials (8, 9) and one meta-analysis (3) have compared hand-sewn to some other pancreatic stump closure procedure.
Both the systematic review of observational studies (9) and the meta-analysis of Knaebel et al. (3) were in favor of stapled closure. This is in agreement with our findings but contrasts with those of two high-volume institutional studies (1,5) that found that stapled stump closure was associated with a higher POPF rate, perhaps because of the crushing injury to the pancreatic parenchyma by the jaws of the linear stapler, and one other high-volume study (10) that did not find any difference. Likewise, the randomized studies of Bassi et al. (8) and Diener et al. (9) both showed a non-statistically significant difference in the POPF rate in favor of hand sewn stump closure. Of note, in all of these studies (1, 3, 8, 9) , the authors did not distinguish between clinically silent and clinically relevant POPF, as we did in our study.
Neither splenic preservation nor splenectomy influenced the POPF rate in our study. Splenic preservation was found to be a significant predictive factor for POPF in two studies (19, 27) Our overall POPF rate was 55%, slightly lower that the Italian randomized trial (65%)(19), but considerably higher than that reported by Diener et al. in the DISPACT trial (9). However, we searched for this complication over a three-month period, compared to the 7 (30%) and 30 day (36%) analyses in the DISPACT trial. Moreover, 15% of their patients had chronic pancreatitis or pseudo-cysts, considered to be at low-risk for development of POPF. (33) involved only expert centers, a potential selection bias.
Laparoscopy was performed in 71 of 270 patients in our study (26%), slightly more than the 20% in the Italian study (19) . Splenic preservation techniques may be easier to perform laparoscopically: almost two thirds of splenic preservation operations (62.0%) were performed via laparoscopy in our study, higher than the 48% rate reported by Montorsi et al. (19) . Our rate of splenic preservation was higher among procedures performed by laparoscopy than by an open approach (48% vs. 14%, P < 0.001), possibly in relation to the 47.4% proportion of benign disease in our study, and facilitating the temptation not to perform splenectomy and to spare splenic vessels with the minimally invasive approach (34). Conversely, it is possible that mandatory preservation of the short gastric vessels in the Warshaw technique (20) might be more difficult to perform laparoscopically explaining why 11/32=34.5% were performed via laparoscopy vs. 21/32=66% via laparotomy in our study.
In contrast to the results in our trial, several studies found that elective closure of the main pancreatic duct had a protective effect (7, 35). However, our study was not powered to determine the role of elective main pancreatic duct closure (secondary end-point in M A N U S C R I P T
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17 our study) on prevention of POPF and to the best of our knowledge, there are no randomized controlled trials on this technical detail in the literature, only multivariate analyses (7, 35).
Possible reasons for the discrepancy of results might be the variation in technical aspects of duct closure from one institution to another, and/or the small number of patients in the studies.
In spite of the outcomes of two randomized controlled studies (11, 12) , the debate as to the need of post-operative drainage (preventive effect on occurrence of clinical POPF or detection of POPF vs. its potential deleterious effects) has never been closed.
Most surgeons in our series (95.6%) left a drain. In our study, there was no difference in the rate or severity of POPF whether patients had a drain or not.
Our study confirms that the use of TachoSil is safe, as it was not associated with any adverse events. This is in accordance with the Italian study (19) as well as a non-interventional multicenter prospective, surveillance study (36) in a total of 3098 patients recruited at 227 centers in 12 European countries.
There are several possible weaknesses in our study. First, 45 centers participated in this multicenter study, possibly explaining the relatively high overall fistula rate and the wide range of techniques used. However, this is representative of real life surgery. Second, our low proportion of malignant disease (53.%) in relation to the literature (1, 3, 19) potentially represents a selection bias, but this also reflects the multicenter character of our study,
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Conclusion
While the concept of reinforcing the stump closure with a resorbable collagen sponge after distal pancreatectomy appeared interesting, our results confirm those from the only other previous controlled trial on this topic: the inability of this adjunctive method to reduce the rate of POPF, whether overall or, as shown in our study only, the rate of clinically relevant POPF. However, it is well known that several studies, especially when the results are negative, are necessary before strong and methodologically sound conclusions can be drawn as to the usefulness or futility of therapeutic decisions (37,38). As one controlled randomized trial 
